Architect of Programmable Biology
Jonathan S. Gootenberg, PhD, has set a distinct example of how modern biology is shifting from observation to engineering. Rather than treating CRISPR as a genome-editing tool alone, his work reframes biology itself as a programmable system – one that can sense, write, and process information.
He co-leads the Abudayyeh–Gootenberg (AbuGoot) Lab, a high-impact research environment known for rapid tool development across CRISPR diagnostics, genome engineering, and enzyme discovery. With 50,000+ Google Scholar citations, Gootenberg’s work has become foundational across CRISPR biology and molecular diagnostics.
Educational Foundation: Training a Tool-Builder
Gootenberg’s scientific style was shaped early. At MIT (2009–2013), he earned dual bachelor’s degrees in Mathematics and Biological Engineering, combining quantitative thinking with hands-on biology. This “dry + wet” integration later became the defining philosophy of his lab.
He went on to pursue a PhD in Systems Biology at Harvard University (2013–2018), conducting doctoral research at the Broad Institute under Feng Zhang and Aviv Regev. During this period, he co-led the discovery of Cas13, extending CRISPR into RNA targeting, and helped develop SHERLOCK, a CRISPR-based diagnostic platform that demonstrated how collateral nuclease activity could be converted into programmable molecular sensing.
This phase established a recurring theme in his career: discover the mechanism, then engineer it into a platform. That logic continues to define the AbuGoot Lab today.
Career Trajectory: Early Independence, by Design
Instead of following a long, conventional postdoctoral route, Gootenberg secured early independence through one of academia’s most selective programs. In 2019, he became an inaugural McGovern Institute Fellow at MIT, allowing him to lead an independent research group immediately after his PhD.
This period focused on mining new enzymes, expanding CRISPR diversity, and building early genome-engineering toolkits. In 2022, he transitioned to a faculty position at Harvard Medical School, with additional appointments within the Beth Israel Deaconess Medical Center and affiliations across the Mass General Brigham research ecosystem.
The AbuGoot Lab now operates at the intersection of academia and translation, moving with what many trainees describe as startup-level speed, but grounded in fundamental biology.
Research Vision: Writing and Sensing Biology
Gootenberg’s lab is unified by a platform-first mindset rather than a single disease focus. Core research directions include:
CRISPR diagnostics: Engineering Cas12 and Cas13 enzymes into ultrasensitive DNA and RNA detection systems.
Genome writing: Developing approaches such as PASTE to insert very large DNA payloads without relying on double-strand breaks.
Enzyme discovery: Identifying RNA-guided enzymes like Fanzors, expanding beyond bacterial CRISPR systems.
AI-guided protein design: Using protein language models to accelerate enzyme evolution and uncover new biological functions.
Applications span genetic disease, cancer, aging, and infectious biology—but the emphasis remains on scalable tools, not narrow mechanisms.
Funding, Translation, and Recognition
The lab is supported by a combination of NIH funding, disease-focused foundations (including support for RNA-targeted therapeutic development), and Harvard–MIT institutional grants. In parallel, Gootenberg is a co-founder of multiple biotechnology companies, including Sherlock Biosciences and Tome Biosciences, translating academic discoveries into deployable platforms.
His contributions have been recognized through honors such as Forbes 30 Under 30 and MIT Technology Review’s 35 Under 35, reflecting influence at the interface of science, engineering, and biotechnology.
Research Paper Decoded Quick Take
If you are interested in CRISPR diagnostics, programmable genome integration, or enzyme discovery at near-startup velocity, the AbuGoot Lab represents one of the most tool-driven research environments in modern biology.
Current research focus: Programmable genome writing · RNA-guided enzymes · CRISPR diagnostics · AI-driven protein design